OSMR Antibody

1. Polymorphisms of the OSMR rs2292016 locus are related to the development and outcome of DCM. PMID:29652994
2. Missense mutatios were found in exon 10 of the oncostatin-M specific receptor beta subunit (OSMR) gene in all of the six patients from family 1, and in exon 14 of the OSMR gene in all of the four patients from family 2. PMID:29419851
3. The PLAC1 expression has been demonstrated for the first time in cervical cancers. This preliminary study has further revealed a complex relationship between PLAC1 expression, cervical cancer histologic type, p53, and HPV type that requires further investigation. PMID:28375929
4. OSMR-beta deficiency in macrophages improved high-fat diet-induced atherogenesis and plaque vulnerability PMID:28258089
5. OSM and OSMR are highly expressed in inflammatory bowel disease intestinal mucosa compared to control mucosa. Intestinal stromal cells express abundant OSMR. PMID:28368383
6. OSM:OSMR interactions are able to induce EMT, increased cancer stem cell-like properties and enhanced lung colonisation in SCC cells PMID:27351213
7. the RET p.S891A mutation combined with OSMR p.G513D may underlie a novel phenotype manifesting as familial medullary thyroid carcinoma and cutaneous amyloidosis PMID:26356818
8. this study offers new findings on the molecular genetics and disease relevance of mutations in OSMR in Familial primary localized cutaneous amyloidosis. PMID:25792357
9. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. PMID:26198770
10. OSMRBeta in neurons is critical for neuronal survival during cerebral ischemic/reperfusion. PMID:26311783
11. primary localized cutaneous amyloidosis has a missense mutation in oncostatin M receptor beta PMID:25054142
12. The interleukin IL-31/IL-31receptor axis contributes to tumor growth in human follicular lymphoma. PMID:25283844
13. oncostatin M is a cytokine possessing vigorous antiviral and immunostimulatory properties which is released by APC upon interaction with CD40L present on activated CD4+ T cells. PMID:24418171
14. The disease severity of rheumatoid arthritis and systemic lupus erythematosus can be partially affected by the OSMR promoter polymorphisms. PMID:24219225
15. We conclude that an OSMR/TGM2/integrin-alpha5beta1/fibronectin pathway is of biological significance in cervical squamous cell carcinoma PMID:23765377
16. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor. PMID:22829597
17. enhanced production by beta-defensin-2 in T cells PMID:22137028
18. This study identified a new heterozygous OSMR missense mutation in primary localized cutaneous amyloidosis. PMID:22062952
19. An alternatively spliced variant of OSMR transcribing a soluble form of this receptor has been characterized in esophageal squamous cell carcinoma. PMID:21394648
20. We conclude that OSMR overexpression in cervical SCC cells provides increased sensitivity to OSM, which induces pro-malignant changes. PMID:21952923
21. Aberrant methylation of the OSMR gene is associated with non-invasive colorectal cancer. PMID:21508378
22. Two new pathogenic heterozygous missense mutations in the OSMR gene (p.Val631Leu and p.Asp647Tyr) were identified in two Dutch familial primary localized cutaneous amyloidosis families. PMID:20507362
23. study provides evidence for the existence of a novel pathogenic mutation in the OSMR gene in a caucasian family with familial primary cutaneous amyloidosis PMID:19466957
24. The identification of OSMR and IL31RA gene pathology provides an explanation of the high prevalence of primary cutaneous amyloidosis in Taiwan as well as new insight into disease pathophysiology. PMID:19690585
25. provides a biologic rationale for silencing of OSMR in colon cancer progression and highlight a new therapeutic target. Moreover, detection and quantification of OSMR promoter methylation in fecal DNA is a highly specific diagnostic biomarker for CRC PMID:19662090
26. expression and evidence for STAT3 activation in human ovarian carcinomas PMID:12061840
27. The expression of OSM and its receptor in ovarian tissue from fetuses and women suggests a possible role of OSM in growth initiation of human primordial follicles. PMID:15831292
28. sOSMR is able to bind OSM and interleukin-31 when associated to soluble gp130 or soluble interleukin-31R, respectively, and to neutralize both cytokine properties PMID:17028186
29. FPLCA has been mapped to 5p13.1-q11.2, and by candidate gene analysis, study identified missense mutations in the OSMR gene, encoding oncostatin M-specific receptor beta (OSMRbeta), in three families. PMID:18179886
30. murine OSMR initiates STAT5 activation directly via the receptor bound Janus kinases. Intriguingly, the murine receptor preferentially recruits JAK2, whereas the human receptor seems to have a higher affinity for JAK1. PMID:18430728
31. IL-6 and Oncostatin M individually affect the profile of leukocyte trafficking PMID:18641356
32. The renal parenchyma is capable of generating a strong acute phase response, likely mediated via OSM/OSMR. PMID:19158344
33. Epigenetic silencing and DNA methylation of OSMR is associated with colorectal cancers. PMID:19223499
34. study reporta a Japanese family with familial primary localized cutaneous amyloidosis in whom a novel OSMR mutation was observed PMID:19375894

Show More

Hide All

HGNC: 8507

UNIGENE: Hs.120658

KEGG: hsa:9180

STRING: 9606.ENSP00000274276

OMIM: 105250